Skip to main content
Fig. 4 | BMC Infectious Diseases

Fig. 4

From: Development and clinical evaluation of a rapid antibody lateral flow assay for the diagnosis of SARS-CoV-2 infection

Fig. 4

Expression and purification of N protein and S1 protein of SARS-CoV-2. a SDS-PAGE analysis of N protein showing its expression in E. coli. M: premixed protein marker. 1: protein extracts of uninduced E. Coli. 2: supernatant after sonication. 3: supernatant after washing pellets with 2 M urea. 4: 8 M urea solution of the pellet. b SDS-PAGE analysis of S1 protein showing its expression in E. coli. M: premixed protein marker. 1: protein extracts of uninduced E. coli. 2: supernatant after sonication. 3: supernatant after washing inclusion bodies with 2 M urea. 4: S1 protein dissolved in 8 M urea. c SDS-PAGE analysis of N protein after purification on the Ni-NTA column. M: premixed protein marker. N: N protein purified on the Ni-NTA column. d SDS-PAGE analysis of purified S1 protein. M: premixed protein marker. S1: purified S1 protein after re-folding

Back to article page